<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Suspected brain tumour (2WW) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Suspected brain tumour (2WW)</h1>
        <div class="sub">Evidence summary (key statements + how they fit together) → DGRefHelp first draft (D&G).</div>
      </div>
    </div>

    <div class="tabs" data-tabs>
      <div class="tab-list" role="tablist">
        <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence summary (triangulated)</button>
        <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
        <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
      </div>

      <div class="tab-panel" role="tabpanel" id="evidence">
        <div class="section">
          <h2>NICE NG12: Suspected cancer (2015, updated 2026)</h2>
          <ul>
            <li><strong>Adults:</strong> Consider an urgent, direct access MRI scan of the brain (or CT scan if MRI is contraindicated; to be done within 2 weeks) to assess for brain or central nervous system cancer in adults with <strong>progressive, sub-acute loss of central neurological function</strong>.</li>
            <li><strong>Children and young people:</strong> Consider a very urgent referral (for an appointment within 48 hours) for suspected brain or central nervous system cancer in children and young people with newly abnormal cerebellar or other central neurological function.</li>
          </ul>

          <h2>Clinical context (Red Flags)</h2>
          <p>While NG12 focuses on "progressive loss of function", other guidelines (e.g., NICE CKS, SIGN) highlight red flags that may require urgent admission or referral:</p>
          <ul>
            <li>Headache with red flags: New onset >50, thunderclap, waking from sleep, precipitated by Valsalva, associated with vomiting/visual change/focal deficit.</li>
            <li>Papilloedema (requires urgent same-day ophthalmology or medical assessment).</li>
            <li>New onset seizure (adult).</li>
            <li>Personality/behaviour change (confirmed by witness).</li>
          </ul>
        </div>
      </div>

      <div class="tab-panel" role="tabpanel" id="draft" hidden>
        <div class="callout">
          <strong>Copy/paste HTML</strong>
          <p class="small">Copy these blocks into the CMS. The CSS classes (<code>callout</code>, <code>check-list</code>, etc.) match the live site.</p>
          
          <details>
            <summary>1. Background</summary>
            <pre><code>&lt;h2&gt;Background&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;Brain tumours are rare but serious; early diagnosis improves outcomes.&lt;/li&gt;
  &lt;li&gt;Symptoms depend on location and growth rate.&lt;/li&gt;
  &lt;li&gt;Most headaches are benign (primary headache disorders), but specific &quot;red flags&quot; warrant investigation.&lt;/li&gt;
  &lt;li&gt;Direct access MRI (or CT) is the primary investigation for adults with progressive sub-acute neurological deficits.&lt;/li&gt;
&lt;/ul&gt;</code></pre>
          </details>

          <details>
            <summary>2. Assessment</summary>
            <pre><code>&lt;h2&gt;Assessment&lt;/h2&gt;
&lt;h3&gt;History&lt;/h3&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Neurological deficit:&lt;/strong&gt; Progressive weakness, sensory loss, coordination/balance issues, speech difficulty, visual field loss.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Headache:&lt;/strong&gt; New onset (esp. &gt;50), waking from sleep, worse in morning/lying down, precipitated by Valsalva, associated with vomiting.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Seizures:&lt;/strong&gt; New onset focal or generalised seizure in an adult.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Personality/Cognitive:&lt;/strong&gt; New confusion, memory loss, or personality change (confirmed by witness).&lt;/li&gt;
&lt;/ul&gt;

&lt;h3&gt;Examination&lt;/h3&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Neurological exam:&lt;/strong&gt; Cranial nerves, limbs (tone, power, reflexes, sensation), coordination (cerebellar signs), gait.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Fundoscopy:&lt;/strong&gt; Check for papilloedema (blurred disc margins).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Visual fields:&lt;/strong&gt; Confrontation testing.&lt;/li&gt;
&lt;/ul&gt;</code></pre>
          </details>

          <details>
            <summary>3. Primary Care Management</summary>
            <pre><code>&lt;h2&gt;Primary Care Management&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Urgent Admission/Same-day Referral:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Signs of raised intracranial pressure (e.g., papilloedema, reduced consciousness).&lt;/li&gt;
      &lt;li&gt;Acute severe headache (thunderclap) &amp;ndash; suspect SAH.&lt;/li&gt;
      &lt;li&gt;Rapidly progressive neurological deficit.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Direct Access Imaging (USC/2WW):&lt;/strong&gt; Refer for imaging if stable but meets criteria.&lt;/li&gt;
  &lt;li&gt;Do not delay referral for blood tests unless specifically indicated (e.g., infection screen if abscess suspected).&lt;/li&gt;
&lt;/ul&gt;</code></pre>
          </details>

          <details>
            <summary>4. Who to refer</summary>
            <pre><code>&lt;h2&gt;Who to refer&lt;/h2&gt;
&lt;h3&gt;Adults (Direct Access Imaging / USC Referral)&lt;/h3&gt;
&lt;ul&gt;
  &lt;li&gt;Consider urgent direct access &lt;strong&gt;MRI brain&lt;/strong&gt; (or CT if MRI contraindicated) to be done within 2 weeks for adults with &lt;strong&gt;progressive, sub-acute loss of central neurological function&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;

&lt;h3&gt;Children and Young People (Urgent Referral)&lt;/h3&gt;
&lt;ul&gt;
  &lt;li&gt;Consider very urgent referral (appointment within 48 hours) for children/young people with &lt;strong&gt;newly abnormal cerebellar or other central neurological function&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;</code></pre>
          </details>
          
           <details>
            <summary>5. Who not to refer</summary>
            <pre><code>&lt;h2&gt;Who not to refer&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;Long-standing stable headaches without red flags (manage as primary headache disorder).&lt;/li&gt;
  &lt;li&gt;Dizziness/vertigo without focal neurological signs (consider BPPV/vestibular neuritis - see &lt;a href=&quot;./dizziness-vertigo.html&quot;&gt;Dizziness&lt;/a&gt; page).&lt;/li&gt;
&lt;/ul&gt;</code></pre>
          </details>
          
           <details>
            <summary>6. Local agreement needed</summary>
            <pre><code>&lt;h2&gt;Local agreement needed&lt;/h2&gt;
&lt;div class=&quot;callout&quot;&gt;
  &lt;ul class=&quot;check-list&quot;&gt;
    &lt;li&gt;&lt;label&gt;&lt;input type=&quot;checkbox&quot; /&gt; Confirm local direct access imaging route: Is it MRI first-line for all, or CT first?&lt;/label&gt;&lt;/li&gt;
    &lt;li&gt;&lt;label&gt;&lt;input type=&quot;checkbox&quot; /&gt; Confirm referral mechanism for children: Paediatric Assessment Unit vs Outpatient Urgent Referral?&lt;/label&gt;&lt;/li&gt;
    &lt;li&gt;&lt;label&gt;&lt;input type=&quot;checkbox&quot; /&gt; Is there a specific &quot;Suspected Brain Tumour&quot; electronic referral form, or use generic USC?&lt;/label&gt;&lt;/li&gt;
  &lt;/ul&gt;
&lt;/div&gt;</code></pre>
          </details>
        </div>

        <div id="draftText" class="section">
          <h2>Background</h2>
          <ul>
            <li>Brain tumours are rare but serious; early diagnosis improves outcomes.</li>
            <li>Symptoms depend on location and growth rate.</li>
            <li>Most headaches are benign (primary headache disorders), but specific "red flags" warrant investigation.</li>
            <li>Direct access MRI (or CT) is the primary investigation for adults with progressive sub-acute neurological deficits.</li>
          </ul>

          <h2>Assessment</h2>
          <h3>History</h3>
          <ul>
            <li><strong>Neurological deficit:</strong> Progressive weakness, sensory loss, coordination/balance issues, speech difficulty, visual field loss.</li>
            <li><strong>Headache:</strong> New onset (esp. >50), waking from sleep, worse in morning/lying down, precipitated by Valsalva, associated with vomiting.</li>
            <li><strong>Seizures:</strong> New onset focal or generalised seizure in an adult.</li>
            <li><strong>Personality/Cognitive:</strong> New confusion, memory loss, or personality change (confirmed by witness).</li>
          </ul>

          <h3>Examination</h3>
          <ul>
            <li><strong>Neurological exam:</strong> Cranial nerves, limbs (tone, power, reflexes, sensation), coordination (cerebellar signs), gait.</li>
            <li><strong>Fundoscopy:</strong> Check for papilloedema (blurred disc margins).</li>
            <li><strong>Visual fields:</strong> Confrontation testing.</li>
          </ul>

          <h2>Primary Care Management</h2>
          <ul>
            <li><strong>Urgent Admission/Same-day Referral:</strong>
              <ul>
                <li>Signs of raised intracranial pressure (e.g., papilloedema, reduced consciousness).</li>
                <li>Acute severe headache (thunderclap) – suspect SAH.</li>
                <li>Rapidly progressive neurological deficit.</li>
              </ul>
            </li>
            <li><strong>Direct Access Imaging (USC/2WW):</strong> Refer for imaging if stable but meets criteria.</li>
            <li>Do not delay referral for blood tests unless specifically indicated (e.g., infection screen if abscess suspected).</li>
          </ul>

          <h2>Who to refer</h2>
          <h3>Adults (Direct Access Imaging / USC Referral)</h3>
          <ul>
            <li>Consider urgent direct access <strong>MRI brain</strong> (or CT if MRI contraindicated) to be done within 2 weeks for adults with <strong>progressive, sub-acute loss of central neurological function</strong>.</li>
          </ul>

          <h3>Children and Young People (Urgent Referral)</h3>
          <ul>
            <li>Consider very urgent referral (appointment within 48 hours) for children/young people with <strong>newly abnormal cerebellar or other central neurological function</strong>.</li>
          </ul>

          <h2>Who not to refer</h2>
          <ul>
            <li>Long-standing stable headaches without red flags (manage as primary headache disorder).</li>
            <li>Dizziness/vertigo without focal neurological signs (consider BPPV/vestibular neuritis - see <a href="./dizziness-vertigo.html">Dizziness</a> page).</li>
          </ul>

          <h2>Local agreement needed</h2>
          <div class="callout">
            <ul class="check-list">
              <li><label><input type="checkbox" /> Confirm local direct access imaging route: Is it MRI first-line for all, or CT first?</label></li>
              <li><label><input type="checkbox" /> Confirm referral mechanism for children: Paediatric Assessment Unit vs Outpatient Urgent Referral?</label></li>
              <li><label><input type="checkbox" /> Is there a specific "Suspected Brain Tumour" electronic referral form, or use generic USC?</label></li>
            </ul>
          </div>
        </div>
      </div>

      <div class="tab-panel" role="tabpanel" id="refs" hidden>
        <div class="section">
          <h2>References</h2>
          <ol>
            <li>NICE. <strong>Suspected cancer: recognition and referral (NG12).</strong> London: National Institute for Health and Care Excellence; 2015 (updated January 2026). <a href="https://www.nice.org.uk/guidance/ng12">https://www.nice.org.uk/guidance/ng12</a> [Accessed 18 Feb 2026]</li>
            <li>NICE. <strong>Brain tumours (primary) and brain metastases in adults (NG99).</strong> London: National Institute for Health and Care Excellence; 2018 (updated 2021). <a href="https://www.nice.org.uk/guidance/ng99">https://www.nice.org.uk/guidance/ng99</a> [Accessed 18 Feb 2026]</li>
          </ol>
        </div>
      </div>
    </div>

    <script src="../assets/tabs.js"></script>
  </div>
</body>
</html>
